Senseonics Holdings, Inc. (SENS) Stock Analysis

Company Overview

Senseonics Holdings, Inc. (SENS) is capitalised at $509.18M on the latest close. The company sits in the Healthcare sector, in the Medical Devices industry. The company reports 130 employees.

SENS last closed at $9.63 on September 4, 2026. That is −$0.27 (−2.73%) against the previous close. Over the past 52 weeks the price has ranged from $4.79 to $11.58. The latest close sits 101.04% above that 52-week low.

Financial Health

In fiscal 2025, Senseonics Holdings, Inc. reported revenue of $35.26M. That is +56.89% against the prior fiscal year, when revenue was $22.47M. The same year closed with a net loss of $69.11M. Profit margin runs at −225.34%. That is 223.6 percentage points below the Medical Devices median of −1.69%. Earnings per share on a trailing basis come to −2.24.

Across the 4 fiscal years on file, revenue moves from $16.39M in 2022 to $35.26M in 2025. Of those 4 years, 1 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. Measured against sales, the shares trade at 10.49 times revenue. On price-to-sales that is 3.5 times the Medical Devices median of 2.98. The medians here are taken across 151 Medical Devices companies that report the metric.

The trailing one-year price return is +7.48%. Measured over 10 years, that is −18.88% a year compounded. Beta against the wider market is reported at 1.08. Annualized volatility over the trailing 10 years is 93.5%.

Growth & Income

The record shows no dividend for SENS.

The strongest complete calendar year on file is 2021 at +206.19%; the weakest is 2019 at −64.63%. Of the 9 complete calendar years on file, 1 finished higher. So far in 2026 the price is +74.46%.